| Authors: |
Rahbari M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.rahbari@dkfz-heidelberg.de.; The M3 Research Center, Eberhard-Karls Universität Tübingen, Tübingen, Germany. m.rahbari@dkfz-heidelberg.de.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. m.rahbari@dkfz-heidelberg.de., Gris-Oliver A; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS-Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Ramadori P; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; The M3 Research Center, Eberhard-Karls Universität Tübingen, Tübingen, Germany., Aicher D; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; The M3 Research Center, Eberhard-Karls Universität Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180), Eberhard Karls University, Tübingen, Germany., Sia D; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Malek NP; The M3 Research Center, Eberhard-Karls Universität Tübingen, Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Loomba R; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Bataller R; Liver Unit, Hospital Clinic, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Llovet JM; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS-Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Mathias.Heikenwaelder@med.uni-tuebingen.de.; The M3 Research Center, Eberhard-Karls Universität Tübingen, Tübingen, Germany. Mathias.Heikenwaelder@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC 2180), Eberhard Karls University, Tübingen, Germany. Mathias.Heikenwaelder@med.uni-tuebingen.de. |
